An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe | Zendy

Stephanie Chisholm | Zendy; Nerteley Quaye | Zendy; Michelle Cole | Zendy; H Fredlund | Zendy; Steen Hoffmann | Zendy; Jørgen Skov Jensen | Zendy; M J van de Laar | Zendy; Magnus Unemo | Zendy; C A Ison | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe

Author(s) -

Stephanie Chisholm,

Nerteley Quaye,

Michelle Cole,

H Fredlund,

Steen Hoffmann,

Jørgen Skov Jensen,

M J van de Laar,

Magnus Unemo,

C A Ison

Publication year - 2010

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkq476

Subject(s) - etest , gentamicin , neisseria gonorrhoeae , agar dilution , european union , microbiology and biotechnology , population , gonorrhea , medicine , minimum inhibitory concentration , biology , antibiotics , virology , environmental health , human immunodeficiency virus (hiv) , business , economic policy

The emergence of decreased susceptibility to third-generation, extended-spectrum cephalosporins in Neisseria gonorrhoeae and associated treatment failures highlights the need to consider alternatives for future therapeutic use, such as gentamicin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research